Top

Vivo Efficacy of Blood stable Thiobenzamides 

Active

75N98026Q01123Federal

Response Deadline09/20/2026, 01:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → National Institutes Of Health OlaoView Agency

NAICS

325414 - Biological Product (except Diagnostic) ManufacturingView NAICS

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

(1)

75N98026Q01123 - Vivo Efficacy of Blood stable Thiobenzamides

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseCombined Synopsis

PostedSep 10

Combined Synopsis

Response DeadlineSep 20

Submission deadline

Response Deadline

09/20/2026, 01:00:00 PM UTCin 9 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao

Contacts1 person available

OfficeBETHESDA, MD, 20892, USA

Organization / Agency

Department Of Health And Human Services → National Institutes Of Health Olao

View Agency Profile

Office AddressBETHESDA, MD, 20892, USA

Contacts

Towanda Daniels

contact@example.gov

Full Description

COMBINED SYNOPSIS / SOLICITATION

See attached

Solicitation No.: 75N98026Q01123

Similar Contracts

Same NAICS industry code

NAICS: 325414

New

International

ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV

Solicitation # WS5872093541

Public Services and Procurement Canada, acting on behalf of the Public Health Agency of Canada, has issued an Advanced Contract Award Notice for the procurement of Vaccinia Immunoglobulin intravenous (human), known as VIGIV. This medical product is required to protect against complications arising from vaccinations with live-replicating smallpox vaccines containing the vaccinia virus. The government intends to negotiate a contract with Emergent BioSolutions Canada Inc, provided no other qualified suppliers express interest. The solicitation, identified by number WS5872093541, was posted on September 10, 2026, with a response deadline of September 30, 2026. Other potential suppliers may submit a statement of capabilities by this date to challenge the pre-identified award. The contract is managed by the Department of Public Works and Government Services for performance within Canada.

Department of Public Works and Government Services

POSTED

DEADLINE

Bio-Hazardous Tissue Transport ServicesThis subcontract for Bio-Hazardous Tissue Transport Services supports NIH NIMH research projects by providing specialized transportation of post-mortem brain tissue. The contractor is responsible for the rapid transit of biological specimens from hospitals and medical examiners to the NIH facility within a 150-mile radius of Bethesda. All transport must utilize refrigerated vehicles and temperature-monitoring devices to ensure specimen integrity. The service provider must strictly adhere to OSHA biosafety standards for bio-hazard containment and DOT hazardous materials regulations. This opportunity is managed by the National Institutes of Health Olao under the Department of Health and Human Services, with a response deadline of September 11, 2026.

National Institutes Of Health Olao

POSTED

DEADLINE

Specialty Medical Consumables SupplyThe Specialty Medical Consumables Supply subcontract, issued by the Southern Regional Health Authority under the Government of Jamaica, facilitates the procurement of essential medical supplies. This agreement focuses on the provision of specialized items, including surgical drapes, sterile kits, catheters, and various infection control products. The primary purpose of this contract is to ensure a continuous supply of these critical materials in instances where the demand exceeds the existing inventory held by the prime contractor. Classified under NAICS code 325414, which pertains to pharmaceutical and medical manufacturing, this subcontract is designed to maintain operational readiness within the regional health system. The contract was officially posted on August 22, 2026, and serves as a strategic mechanism to mitigate supply chain risks by providing a secondary source for high-demand medical consumables. Interested parties can access further details and procurement documentation through the official electronic procurement portal provided by the government.

Southern Regional Health Authority

POSTED

DEADLINE

Medical Diagnostic Test Kit SupplyThe Defense Logistics Agency under the Department of Defense has issued a subcontract for the supply of 100 E. coli detection test kits. These diagnostic kits must strictly adhere to FDA regulations, specific shelf-life requirements, and Department of Defense medical packaging standards to ensure quality and viability. Classified under NAICS code 325414, this procurement focuses on the delivery of specialized medical diagnostic tools. The contract was posted on August 11, 2026, and is managed through the DLA's acquisition systems to support military medical readiness.

Defense Logistics Agency

POSTED

DEADLINE

Medical Supply Procurement – Petrolatum GauzeThis subcontract with the Defense Logistics Agency under the Department of Defense involves the manufacture or supply of 27 units of petrolatum gauze, identified by NSN 6510-01-112-6414. The procurement falls under NAICS code 325414 and requires all units to meet strict military medical standards. Key delivery requirements include a minimum shelf life of 36 months, with a mandate that the time elapsed from manufacture to delivery does not exceed five months. The contract was posted on August 10, 2026.

Defense Logistics Agency

POSTED

DEADLINE

Typhoid Vi Polysaccharide Vaccine SupplyThis subcontract through the Defense Logistics Agency under the Department of Defense involves the supply of 1,000 units of FDA-compliant, preserved Typhoid Vi Polysaccharide Vaccine. The procurement is categorized under NAICS code 325414 and is designated for delivery to a U.S. Navy vessel. The agreement is established under FOB Destination terms, ensuring the delivery of the medical supplies to the specified naval location. The contract was posted on August 10, 2026, and is managed via the DIBBS system.

Defense Logistics Agency

POSTED

DEADLINE

Supply and Delivery of Typhoid VI Polysaccharide Vaccine (NSN 6505015334962)This subcontract with the Defense Logistics Agency involves the procurement, packaging, and delivery of 1,000 units of preservative-free Typhoid VI Polysaccharide Vaccine. The product must comply with NDC 49281-0790-51 and NSN 6505015334962. The vaccines are to be delivered to the USS Theodore Roosevelt (CVN 71) at FPO AP 96632 by August 10, 2026. Shipping must be handled via FOB Destination using fast and traceable methods to ensure secure arrival.

Defense Logistics Agency

POSTED

DEADLINE

MMR Vaccine Supply and Delivery

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Product Supply – Aluminum Hydroxide Gel

Defense Logistics Agency

POSTED

DEADLINE

Measles, Mumps, and Rubella (MMR) Vaccine Supply and DeliveryThe contract entails the supply and delivery of three units of Measles, Mumps, and Rubella vaccine to a U.S. Navy vessel at a forward operating base destination, with strict requirements for traceable express shipping and full compliance with established medical handling standards. The contractor is responsible for ensuring the vaccines remain viable throughout transit by adhering to temperature control, packaging, and documentation protocols mandated for biological materials. This is a subcontract under the Department of Defense, managed by the Defense Logistics Agency, with a NAICS code of 325414 indicating pharmaceutical preparation manufacturing. The delivery must be completed in accordance with military logistics guidelines, and all shipping records must maintain a verifiable chain of custody from origin to final receipt aboard the vessel. The contract was posted on August 9, 2026, and the place of performance is tied to a military operational location, though specific geographic details are not provided. The award reference number SPE2DX25D8022 and delivery identifier SPE2D926F8119 are linked to the official DLA procurement system, underscoring the mission-critical nature of timely and secure delivery. While the solicitation number is not listed, the subcontract structure suggests coordination with a prime contractor to fulfill the DOD’s medical readiness requirements. All activities must comply with federal regulations governing vaccine distribution and military supply chain integrity.

Defense Logistics Agency

POSTED

DEADLINE

Supply of Tetanus and Diphtheria Toxoids, Adsorbed Vaccine

Defense Logistics Agency

POSTED

DEADLINE

Biological Pharmaceutical Supply – Tetanus and Diphtheria ToxoidsThe contract pertains to the supply of FDA-approved tetanus and diphtheria toxoids, adsorbed, identified by NSN 6505016632617, specifically for delivery to a U.S. Navy vessel. This biological pharmaceutical product is procured under a subcontract by the Defense Logistics Agency on behalf of the Department of Defense, with the NAICS code 325414 indicating manufacturing of biological products. The contract was posted on August 5, 2026, and the place of performance is not specified beyond the requirement for delivery to a naval vessel, suggesting the end use is for military medical readiness. The contract is identified by the procurement number SPE2DX25D8022 and delivery identifier SPE2D926F7957, and while no set-aside type is indicated, the focus is on fulfilling a critical medical supply need for U.S. Navy operations.

Defense Logistics Agency

POSTED

about 1 month ago

DEADLINE

N/A

View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 811212

New

Federal

Specialized Technical Maintenance & Service

Computer and Office Machine Repair and Maintenance

POSTED

DEADLINE

nCounter Pro Equipment Supply

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

10x Genomics Gene Expression and Epigenomic Kit Supplier

Construction and Mining (except Oil Well) Machinery and Equipment Merchant Wholesalers

POSTED

DEADLINE

nCounter Pro Analysis System

Solicitation # 75N98026Q01187

This contract involves the procurement of an nCounter Pro Analysis System, including a prep station and the necessary installation and training kits, for the National Institutes of Health. The agreement includes an initial one-year warranty that begins upon the installation and acceptance of the equipment by the government point of contact. Following the warranty period, the system will be covered by a 48-month Gold service contract for both the system and the prep station. Bruker Spatial Biology is responsible for providing manufacturer-authorized maintenance, technical support, and repairs, including preventive maintenance, software updates, and the replacement of approved parts to ensure the equipment maintains its original performance specifications.

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

Single cell methylation

Solicitation # 75N98026Q01085

The National Institutes of Health Olao, under the Department of Health and Human Services, is seeking a contractor for single cell methylation services under solicitation number 75N98026Q01085. This combined contract opportunity is categorized under NAICS code 334516 and is open to all bidders as there is no set-aside designation. The performance of this contract will take place in Bethesda, Maryland. Interested parties must submit their responses by the deadline of September 20, 2026, at 1:00 PM. The primary point of contact for this requirement is Towanda Daniels.

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

Assay Service for assessing ADME properties and in vivo PK properties with the selected vendor. ENAMINE US INC

Solicitation # 75N98026Q01193ENAMINEUSINCPCANIAAA08396

The Section on Medicinal Chemistry within the National Institutes of Health is seeking chemical reagent assay development and laboratory testing services from Enamine US Inc. This contract focuses on the development of grouped ADME assays and pharmacokinetic studies in C57BL6 mice to evaluate the translational potential of new molecular entities targeting metabolic and alcohol associated diseases. A primary component of this request is the Caco-2 Permeability Assay, which will be used to predict oral absorption potential by mimicking the human intestinal epithelium and analyzing passive diffusion, active transport, and efflux processes. The data generated from these services will inform structure-activity relationship optimization and help reduce transporter-related liabilities to improve bioavailability. This procurement is managed by the Department of Health and Human Services in Bethesda, Maryland, under solicitation number 75N98026Q01193ENAMINEUSINCPCANIAAA08396.

Other Chemical and Allied Products Merchant Wholesalers

POSTED

DEADLINE

Specialized Blood Products-AABB

Solicitation # 26-008618

The National Institutes of Health Clinical Center intends to award a sole-source Indefinite Delivery/Indefinite Quantity contract to the National Blood Exchange of the Association for the Advancement of Blood and Biotherapies. This contract is for the provision of specialized blood products, including rare red blood cells, AB plasma, cryoprecipitate, and single-donor platelets, to support patients in a 200-bed research hospital. The contractor must provide 24/7 accessibility, electronic ordering and tracking, and the ability to source rare, multiple-antigen-negative products from a nationwide network of FDA-licensed facilities in compliance with AABB, CAP, CLIA, and FDA standards. The anticipated annual requirements include 300 to 400 antigen-negative leukoreduced red blood cells, 50 to 100 units of Fresh Frozen AB plasma, and 100 to 200 units of single-donor platelets. The contract will feature a 12-month base period with individual requirements funded through specific orders. While the government intends to proceed with a sole-source award due to the unique capabilities of the National Blood Exchange, interested parties may submit capability statements by September 20, 2026, to demonstrate their ability to meet the full scope of these specialized requirements under NAICS code 621991.

Blood and Organ Banks

POSTED

DEADLINE

Upgrade for LUMICKS C-trap to 3 color confocal instrument

Solicitation # 75N98026Q01151-04750

Solicitation 75N98026Q01151-04750 is a firm-fixed price requirement issued by the National Institutes of Health to upgrade an existing LUMICKS C-trap system (Part # NSR-20346) from a 2-color to a 3-color confocal fluorescence instrument. The scope of work involves the procurement and installation of a 488nm laser to enable the visualization of additional molecules and the use of different fluorophores. The contractor must install the laser within six months of purchase and provide validation ensuring the laser and detector meet installation guide specifications, single molecules are observable at the 488nm wavelength, and the overall instrument function remains unaffected. The system must be maintained in working order with a warranty valid through February 15, 2029, to align with the existing instrument. Performance and delivery will take place at the NIH/NIEHS facility in Research Triangle Park, North Carolina. The acquisition is conducted under the simplified acquisition threshold, not exceeding 350,000 dollars. Evaluation factors for award include technical capability, past performance, maintenance availability, expected lifecycle, special features, trade-in considerations, and energy efficiency. Interested offerors must be registered in the System for Award Management and submit a technical proposal, cost-price proposal, and administrative data, including their Unique Entity ID and Taxpayer Identification Number, to Luz Casey by September 15, 2026.

Electronic and Precision Equipment Repair and Maintenance

POSTED

DEADLINE

Rees Scientific Environmental Monitoring Probes, Transmitters, and Installation

Solicitation # 26-007333

The National Institutes of Health Clinical Center, on behalf of the Department of Transfusion Medicine, intends to award a sole-source, firm-fixed-price contract to Rees Scientific for the procurement and installation of environmental monitoring probes and transmitters. This acquisition is necessary to address deficiencies identified during a Centers for Medicare and Medicaid Services inspection and ensure regulatory compliance for the Human Leukocyte Antigen section. The equipment will monitor critical conditions such as room temperature, humidity, and storage units to maintain the safety and integrity of patient care and blood product manufacturing. Rees Scientific is identified as the sole source due to the proprietary nature of the existing monitoring system, which requires compatible hardware for expansion. While this is not a request for competitive quotations, the government is accepting capability statements from other responsible sources until September 20, 2026. Interested parties must provide documentation proving full compatibility with the current system and reference acquisition number 26-007333 in their submission to Shasheshe Goolsby.

Analytical Laboratory Instrument Manufacturing

POSTED

DEADLINE

Red Hat OpenShift Kubernetes Engine (OKE) and Red Hat Enterprise Linux (RHEL) Subscription Licensing and Deployment Support

Solicitation # 26-009442

The National Institutes of Health Clinical Center intends to award a one-year, sole-source, firm-fixed-price purchase order to Trilogy Innovations, Inc. for Red Hat OpenShift Kubernetes Engine and Red Hat Enterprise Linux software subscriptions. The procurement includes 40 Core Band subscriptions of Red Hat OpenShift Kubernetes Engine Premium and six nodes of Red Hat Enterprise Linux Server with Satellite, both featuring Premium Confirmed Stateside Support. Additionally, Trilogy Innovations will provide up to 20 hours of expert engineering services to assist with installation, configuration, and the operationalization of the environment to support PAS-X onboarding. This acquisition is critical for transitioning the Clinical Center from paper-based processes and the unsupported StemLab application to the PAS-X application, ensuring compliance with federal and state requirements for the manufacture and distribution of human cellular and tissue-based products. Trilogy Innovations will act as the third-party reseller, providing software as a pass-through from Carahsoft Technology Corporation and Red Hat, Inc. while performing the necessary deployment support.

POSTED

DEADLINE

10X Gene expression kits and reagents

Solicitation # 75N98026Q01192

The National Institutes of Health, specifically the National Institute on Aging and the Center for Alzheimer's and Related Dementias, is seeking a provider for 10X Gene expression kits and Single Cell Multiome reagents under solicitation 75N98026Q01192. These materials will be used to conduct spatial analysis and study molecular mechanisms of neurodegenerative diseases with Lewy body pathology, comparing Parkinson's Disease, Dementia with Lewy bodies, and neurologically normal individuals to identify potential therapeutic genes and pathways. This combined contract opportunity is managed by the Department of Health and Human Services in Bethesda, Maryland, under NAICS code 541715. The solicitation was posted on September 10, 2026, with a response deadline of September 21, 2026. Brian Lind serves as the primary point of contact for this requirement.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Transscleral Flood Illumination (TFI) Module Supplier

Military Armored Vehicle, Tank, and Tank Component Manufacturing

POSTED

2 days ago

DEADLINE

in 7 days

View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 650+ contractors already using CLEATUS

​Vivo Efficacy of Blood stable Thiobenzamides​ ​

Contract Overview

General Info

Documents

AI Contract Breakdown

Timeline

Ready to pursue this opportunity?

Organization & Contact Information

Full Description

Similar Contracts

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Get AI-powered intelligence on this solicitation and the ones like it

Vivo Efficacy of Blood stable Thiobenzamides 